GE LIGHTSPEED ACT FP16
K091673 · Ge Medical Systems, Inc. · JAK · Jun 24, 2009 · Radiology
Device Facts
| Record ID | K091673 |
| Device Name | GE LIGHTSPEED ACT FP16 |
| Applicant | Ge Medical Systems, Inc. |
| Product Code | JAK · Radiology |
| Decision Date | Jun 24, 2009 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 892.1750 |
| Device Class | Class 2 |
| Attributes | 3rd-Party Reviewed |
Intended Use
When configured as a CT System, the GE LightSpeed ACT FP16 is indicated for head and whole body X-ray computed tomography applications. When configured as a fluoroscopic system, the GE LightSpeed ACT FP16 is indicated for use in generating fluoroscopic images of human anatomy for vascular angiography, cardiology, diagnostic and interventional procedures, and optionally, rotational imaging procedures. It is intended to replace fluoroscopic images obtained through image intensifier technology and is not intended for mammography applications.
Device Story
GE LightSpeed ACT FP16 is a modified CT system designed for integration with GE Innova 4100 Single Plane Digital Fluoroscopic Imaging system. Device features a movable gantry allowing CT scanning while patient remains on a shared x-ray table. Systems operate independently, one at a time. Used in clinical settings by healthcare professionals for diagnostic and interventional procedures. Modification enables rapid transition between CT and fluoroscopic imaging modalities without patient repositioning, improving workflow efficiency and patient comfort during complex interventional procedures.
Clinical Evidence
No clinical data. Verification of modification performed via bench testing and imaging phantoms on a fully configured installation. Performance of equipment movements, user controls, and status displays evaluated by test personnel.
Technological Characteristics
Computed tomography x-ray system with movable gantry. Integrates with digital fluoroscopic imaging system. Conforms to thermal, electrical, radiation, and mechanical safety standards. Design and development conform to 21 CFR 820, ISO 9001, and ISO 13485.
Indications for Use
Indicated for head and whole body CT imaging and fluoroscopic imaging of human anatomy for vascular angiography, cardiology, diagnostic, and interventional procedures. Not for mammography.
Regulatory Classification
Identification
A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
Predicate Devices
- GE HiSpeed X/i Smart Gantry Option (K012385)
Related Devices
- K182223 — Aquilion ONE Self-Propelled Scan Base Kit for IVR-CT, CGBA-034A · Canon Medical Systems, USA · Sep 14, 2018
- K012385 — HISPEED X/I SMART GANTRY OPTION · Ge Medical Systems, Inc. · Aug 10, 2001
- K134025 — AQUILION ONE VISION SELF-PROPELLED SCAN BASE KIT FOR IVR-CT · Toshibamedical Systems Corporation · Sep 5, 2014
- K143223 — CGBA-032A, Aquilion PRIME Self-Propelled Scan Base Kit for IVR-CT · Toshibamedical Systems Corporation · Jan 12, 2015
- K233749 — Revolution Ascend Sliding · Ge Hangwei Medical Systems Co., Ltd. · Feb 22, 2024
Submission Summary (Full Text)
{0}------------------------------------------------
KC91673
Special 510(k) Premarket Notification GE LiahtSpeed ACT FP16 Modification Revised June 15, 2009
## Attachment B:
JUN 2 4 2009
Summary of Safety and Effectiveness Prepared in accordance with 21 CFR Part 807.92(c).
| | | <i>GE Healthcare, P.O. Box 414, Milwaukee, WI 53201</i> |
|-------------|------------------|-----------------------------------------------------------------------------------------------------------|
| Section a): | | |
| 1. | Submitter: | GE Medical Systems, LLC doing business as GE Healthcare<br>3000 N. Grandview Blvd.<br>Waukesha, WI 53188 |
| | Contact Person: | Allen Schuh, Regulatory Affairs Manager<br>9900 Innovation Drive, Mail Stop RP2138<br>Wauwatosa, WI 53226 |
| | Date Prepared: | June 16, 2009 |
| 2. | Device Name: | GE LightSpeed ACT FP16<br>Computed Tomography X-Ray System, 21 CFR 892.1750, 90J--AK |
| 3. | Marketed Device: | GE HiSpeed X/i Smart Gantry Option |
- 4. Device Description: The GE LightSpeed ACT FP16 is a modified CT system intended to be located in close proximity to a GE Innova 4100 Single Plane Digital Fluoroscopic Imaging system utilizing a single patient table which can be configured for interventional x-ray or CT imaging procedures. This modification allows the patient to remain on the x-ray table which can be quickly configured for CT scanning via a movable gantry. Both the CT and X-ray systems are used separately, one at a time, in accordance with their respective indications for use.
- 5. Indications for Use: When configured as a CT System, the GE LightSpeed ACT FP16 is indicated for head and whole body X-ray computed tomography applications. When configured as a fluoroscopic system, the GE LightSpeed ACT FP16 is indicated for use in generating fluoroscopic images of human anatomy for vascular angiography, cardiology, diagnostic and interventional procedures, and optionally, rotational imaging procedures. It is intended to replace fluoroscopic images obtained through image intensifier technology and is not intended for mammography applications.
- 6. Comparison with Predicate Device: GE LightSpeed ACT FP16 is substantially equivalent in tems of safety and effectiveness to the GE HiSpeed X/i Smart Gantry Option (K012385). Both systems utilize a movable CT gantry to scan the patient while placed on a stationary table. They have the same technological characteristics, are comparable in key safety and effectiveness features, utilize similar design, construction, and materials and share the same intended use and clinical purpose.
#### Section b):
1. Non-clinical Tests: The modifications have been evaluated for conformance to specifications and overall performance as well as for thermal, electrical, radiation and mechanical safety as part of the design verification by employees of the manufacturer and by an independent test agency. The product has been found to conform with applicable medical device safety standards.
2. Clinical Tests: None required. Verification of conformance to specifications for the modification was completed with bench testing and imaging phantoms on a fully configured installation. Performance of the equipment movements, user controls and status display was easily evaluated with test equipment and test personnel familiar with clinical practice and procedures.
3. Conclusion: Intended uses and other key features are consistent with traditional clinical practice, FDA guidelines, and established methods of patient examination. The design and development process of the manufacturer conforms to 21 CFR 820, ISO 9001 and 13485 quality systems. The device conforms to applicable medical device safety standards and compliance is verified through independent evaluation with ongoing factory surveillance. Therefore, it is the opinion of GE Healthcare that the GE LightSpeed ACT FP16 is substantially equivalent with respect to safety and effectiveness to devices currently cleared for market.
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle.
#### DEPARTMENT OF HEALTH & HUMAN SERVICES ..
Public-Health-Service_
JUN 2 4 2009
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
GE Medical Systems LLC % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLS 1394 25" Street NW BUFFALO MN 55313
Re: K091673
Trade/Device Name: GE LightSpeed™ ACT FP16 Modification Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: JAK, JAA Dated: June 5, 2009 Received: June 9, 2009
#### Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
{2}------------------------------------------------
Page 2
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrh/mdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Sincerely yours,
Jadine M. Morris
Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Special 510(k) Premarket Notification GE LightSpeed ACT FP16 Modification Revised June 15, 2009
# Attachment E
### Indications for Use
510(k) Number (if known): K091673
Device Name: GE LightSpeed™ ACT FP16 Modification
Indications For Use of GE LightSpeed™ ACT FP16 when configured as a CT System:
The GE LightSpeed™ ACT FP16 is indicated for head and whole body X-ray computed tomography applications.
Indications For Use of GE LightSpeed™ ACT FP16 when configured as a Fluoroscopic System: .
GE LightSpeed™ ACT FP16 is indicated for use in generating fluoroscopic images of SE Elghtopeda. nonedures, and optionally, rotational imaging procedures. It is intended to replace procedures, and optionally, rethnology image intensifier technology and is not intended for mammography applications.
| Prescription Use<br>(Part 21 CFR 801 Subpart D) | X | AND/OR | Over-The-Counter Use<br>(21 CFR 801 Subpart C) |
|-------------------------------------------------|---|--------|------------------------------------------------|
|-------------------------------------------------|---|--------|------------------------------------------------|
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
|-----------------------------------------------------------------|---------|
| Division of Reproductive, Abdominal and<br>Radiological Devices | |
| 510(k) Number | K091673 |
Page 1 of 1